| Active ingredients | Dosage form | Quantity of active ingredients | Shortage status | Availability | Reason | Last updated |
| prazosin hydrochloride | Tablet, uncoated | 1.095 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 24/10/2025 |
| prazosin hydrochloride | Tablet, uncoated | 2.19 mg | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 24/10/2025 |
| prazosin hydrochloride | Tablet, uncoated | 5.476 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 24/10/2025 |
| ramipril | Tablet, uncoated | 1.25 mg | Resolved | Available | Manufacturing | 24/10/2025 |
| trandolapril | Capsule | 2 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 24/10/2025 |
| tranexamic acid | Tablet, film coated | 500 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 24/10/2025 |
| clopidogrel hydrogen sulfate | Tablet, film coated | 97.875 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 24/10/2025 |
| risperidone | Tablet, film coated | 2 mg | Current | Limited Availability | Manufacturing | 24/10/2025 |
| bisoprolol fumarate | Tablet | 2.5 mg | Current | Unavailable | Manufacturing | 24/10/2025 |
| clopidogrel hydrogen sulfate | Tablet, film coated | 97.9 mg | Current | Limited Availability | Unexpected increase in consumer demand | 24/10/2025 |
| exemestane | Tablet, sugar coated | 25 mg | Anticipated | Available | Manufacturing | 24/10/2025 |
| indapamide hemihydrate | Tablet, sugar coated | 2.5 mg | Current | Limited Availability | Manufacturing | 24/10/2025 |
| ropivacaine hydrochloride | Injection, solution | 200 mg | Current | Unavailable | Transport / Logistic issues / Storage capacity issues | 24/10/2025 |
| clopidogrel besilate | Tablet, film coated | 112.1 mg | Current | Unavailable | Manufacturing | 24/10/2025 |
| pramipexole dihydrochloride monohydrate | Tablet | .125 mg | Current | Unavailable | Unexpected increase in consumer demand | 24/10/2025 |
| pramipexole dihydrochloride monohydrate | Tablet | .25 mg | Current | Unavailable | Unexpected increase in consumer demand | 24/10/2025 |
| rosuvastatin calcium | Tablet, film coated | 10.42 mg | Current | Unavailable | Manufacturing | 24/10/2025 |
| pregabalin | Capsule, hard | 150 mg | Current | Limited Availability | Unexpected increase in consumer demand | 24/10/2025 |
| levetiracetam | Solution | 100 mg/mL | Resolved | Available | Manufacturing | 24/10/2025 |
| clonidine hydrochloride | Tablet | 100 microgram | Resolved | Available | Unexpected increase in consumer demand | 24/10/2025 |
| tranexamic acid | Tablet, film coated | 500 mg | Current | Limited Availability | Manufacturing | 24/10/2025 |
| tranexamic acid | Tablet, film coated | 500 mg | Current | Unavailable | Manufacturing | 24/10/2025 |
| cyproterone acetate | Tablet, uncoated | 50 mg | Current | Unavailable | Manufacturing | 24/10/2025 |
| hydrocortisone | Tablet, uncoated | 4 mg | Current | Limited Availability | Manufacturing | 24/10/2025 |
| nizatidine | Capsule, hard | 150 mg | Resolved | Available | Manufacturing | 24/10/2025 |
| nizatidine | Capsule, hard | 150 mg | Current | Unavailable | Manufacturing | 24/10/2025 |
| rasagiline mesilate | Tablet | 1.56 mg | Anticipated | Available | Manufacturing | 24/10/2025 |
| ambrisentan | Tablet, film coated | 10 mg | Anticipated | Available | Manufacturing | 24/10/2025 |
| teriflunomide | Tablet, film coated | 14 mg | Current | Limited Availability | Manufacturing | 24/10/2025 |
| gabapentin | Tablet, film coated | 600 mg | Anticipated | Available | Manufacturing | 24/10/2025 |
| hydrochlorothiazide~amlodipine besilate~olmesartan medoxomil | Tablet, film coated | 12.5 mg~13.9 mg~40 mg | Current | Limited Availability | Manufacturing | 24/10/2025 |
| paclitaxel | Injection, powder for | 100 mg | Current | Limited Availability | Manufacturing | 24/10/2025 |
| clopidogrel hydrogen sulfate | Tablet, film coated | 97.875 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 24/10/2025 |
| tranexamic acid | Tablet, film coated | 500 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 24/10/2025 |
| ethinylestradiol~norethisterone | Tablet, uncoated | 36 microgram~500 microgram | Anticipated | Available | Manufacturing | 24/10/2025 |
| pramipexole dihydrochloride monohydrate | Tablet, uncoated | 1 mg | Anticipated | Available | Unexpected increase in demand due to other sponsors unable to supply | 24/10/2025 |
| prazosin hydrochloride | Tablet, uncoated | 1.1 mg | Current | Unavailable | Manufacturing | 24/10/2025 |
| prazosin hydrochloride | Tablet, uncoated | 2.2 mg | Current | Unavailable | Manufacturing | 24/10/2025 |
| prazosin hydrochloride | Tablet, uncoated | 5.5 mg | Current | Unavailable | Manufacturing | 24/10/2025 |
| trandolapril | Capsule | 4 mg | Resolved | Available | Manufacturing | 24/10/2025 |
| dinoprostone | Gel | .6667 mg/g | Anticipated | Available | Manufacturing | 24/10/2025 |
| risperidone | Tablet, film coated | 2 mg | Resolved | Available | Manufacturing | 23/10/2025 |
| topiramate | Tablet, film coated | 25 mg | Current | Unavailable | Manufacturing | 23/10/2025 |
| olanzapine | Tablet, orally disintegrating | 20 mg | Resolved | Available | Manufacturing | 23/10/2025 |
| phenoxymethylpenicillin potassium | Oral Liquid, powder for | 28.284 mg/mL | Current | Unavailable | Manufacturing | 23/10/2025 |
| levetiracetam | Tablet, film coated | 500 mg | Current | Unavailable | Manufacturing | 23/10/2025 |
| levetiracetam | Tablet, film coated | 1000 mg | Current | Unavailable | Manufacturing | 23/10/2025 |
| olanzapine | Tablet, orally disintegrating | 10 mg | Current | Unavailable | Manufacturing | 23/10/2025 |
| olanzapine | Tablet, orally disintegrating | 5 mg | Current | Unavailable | Manufacturing | 23/10/2025 |
| clopidogrel hydrogen sulfate | Tablet, film coated | 97.875 mg | Current | Limited Availability | Unexpected increase in consumer demand | 23/10/2025 |
| lansoprazole | Tablet, orally disintegrating | 30 mg | Current | Limited Availability | Manufacturing | 23/10/2025 |
| sildenafil citrate | Tablet, film coated | 28.1 mg | Current | Unavailable | Manufacturing | 23/10/2025 |
| isotretinoin | Capsule, soft | 10 mg | Current | Unavailable | Manufacturing | 23/10/2025 |
| isotretinoin | Capsule, soft | 20 mg | Current | Unavailable | Manufacturing | 23/10/2025 |
| ezetimibe~simvastatin | Tablet | 10 mg~10 mg | Current | Unavailable | Manufacturing | 23/10/2025 |
| ezetimibe~simvastatin | Tablet | 10 mg~20 mg | Current | Unavailable | Manufacturing | 23/10/2025 |
| rosuvastatin calcium | Tablet, film coated | 20.84 mg | Current | Unavailable | Unexpected increase in consumer demand | 23/10/2025 |
| ezetimibe | Tablet, uncoated | 10 mg | Current | Unavailable | Unexpected increase in consumer demand | 23/10/2025 |
| irbesartan | Tablet, film coated | 150 mg | Resolved | Available | Manufacturing | 23/10/2025 |
| cyproterone acetate | Tablet, uncoated | 100 mg | Anticipated | Available | Manufacturing | 23/10/2025 |
| atorvastatin calcium trihydrate | Tablet, film coated | 86.76 mg | Current | Unavailable | Manufacturing | 23/10/2025 |
| efavirenz~tenofovir disoproxil maleate~emtricitabine | Tablet, film coated | 600 mg~300 mg~200 mg | Current | Unavailable | Manufacturing | 23/10/2025 |
| olmesartan medoxomil~hydrochlorothiazide | Tablet | 20 mg~12.5 mg | Anticipated | Available | Manufacturing | 23/10/2025 |
| bimatoprost | Eye Drops | .3 mg/mL | Anticipated | Available | Manufacturing | 23/10/2025 |
| nitrofurantoin | Capsule, hard | 100 mg | Resolved | Available | Manufacturing | 23/10/2025 |
| Teriparatide | Injection, solution | .25 mg/mL | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 23/10/2025 |
| naltrexone hydrochloride | Tablet, film coated | 50 mg | Anticipated | Available | Manufacturing | 23/10/2025 |
| levothyroxine sodium | Tablet | 200 microgram | Current | Unavailable | Unexpected increase in consumer demand | 23/10/2025 |
| rivaroxaban | Tablet, film coated | 10 mg | Anticipated | Available | Manufacturing | 23/10/2025 |
| tamoxifen citrate | Tablet, uncoated | 15.2 mg | Current | Unavailable | Manufacturing | 23/10/2025 |
| tamoxifen citrate | Tablet, uncoated | 30.4 mg | Current | Unavailable | Manufacturing | 23/10/2025 |
| isotretinoin | Capsule, soft | 20 mg | Current | Unavailable | Manufacturing | 23/10/2025 |
| isotretinoin | Capsule, soft | 10 mg | Anticipated | Available | Manufacturing | 23/10/2025 |
| mupirocin | Ointment | 20 mg/g | Current | Unavailable | Manufacturing | 23/10/2025 |
| lidocaine hydrochloride | Injection, solution | 10 mg/mL | Resolved | Available | Manufacturing | 23/10/2025 |
| ropivacaine hydrochloride | Injection, solution | 10 mg/mL | Resolved | Available | Manufacturing | 23/10/2025 |
| phenylephrine hydrochloride | Injection, solution | 10 mg/mL | Anticipated | Available | Manufacturing | 22/10/2025 |
| galantamine hydrobromide | Capsule, modified release | 30.768 mg | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 22/10/2025 |
| mycophenolate mofetil | Tablet, film coated | 500 mg | Current | Limited Availability | Manufacturing | 22/10/2025 |
| letrozole | Tablet, film coated | 2.5 mg | Current | Unavailable | Manufacturing | 22/10/2025 |
| atorvastatin calcium trihydrate~amlodipine besilate | Tablet, film coated | 43.376 mg~6.94 mg | Current | Unavailable | Manufacturing | 22/10/2025 |
| atorvastatin calcium trihydrate~amlodipine besilate | Tablet, film coated | 10.844 mg~13.88 mg | Current | Unavailable | Manufacturing | 22/10/2025 |
| milrinone | Injection, concentrated | 10 mg | Current | Unavailable | Manufacturing | 22/10/2025 |
| fingolimod hydrochloride | Capsule | 560 microgram | Anticipated | Available | Manufacturing | 22/10/2025 |
| phenytoin sodium | Injection, solution | 250 mg | Current | Limited Availability | Manufacturing | 22/10/2025 |
| bromazepam | Tablet, uncoated | 6 mg | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 22/10/2025 |
| bisoprolol fumarate | Tablet | 2.5 mg | Current | Unavailable | Manufacturing | 21/10/2025 |
| ropivacaine hydrochloride | Injection, solution | 10 mg/mL | Anticipated | Available | Unexpected increase in demand due to other sponsors unable to supply | 21/10/2025 |
| clindamycin hydrochloride | Capsule, hard | 162.87 mg | Anticipated | Available | Manufacturing | 21/10/2025 |
| mesalazine | Tablet, enteric coated | 800 mg | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 21/10/2025 |
| acamprosate calcium | Tablet, enteric coated | 333 mg | Anticipated | Available | Manufacturing | 21/10/2025 |
| moxonidine | Tablet, film coated | 400 microgram | Current | Limited Availability | Manufacturing | 21/10/2025 |
| paroxetine hydrochloride | Tablet, film coated | 22.22 mg | Anticipated | Available | Manufacturing | 21/10/2025 |
| carvedilol | Tablet, film coated | 6.25 mg | Anticipated | Available | Manufacturing | 21/10/2025 |
| lamotrigine | Tablet, chewable | 100 mg | Current | Limited Availability | Manufacturing | 21/10/2025 |
| lamotrigine | Tablet, chewable | 200 mg | Anticipated | Available | Manufacturing | 21/10/2025 |
| ondansetron hydrochloride dihydrate | Tablet, film coated | 4.986 mg | Anticipated | Available | Manufacturing | 21/10/2025 |
| famciclovir | Tablet, film coated | 250 mg | Current | Unavailable | Manufacturing | 21/10/2025 |
| famciclovir | Tablet, film coated | 500 mg | Current | Unavailable | Manufacturing | 21/10/2025 |
| ondansetron hydrochloride dihydrate | Injection, solution | 5 mg | Current | Unavailable | Manufacturing | 20/10/2025 |
| midazolam | Injection, solution | 50 mg | Current | Limited Availability | Manufacturing | 20/10/2025 |
| vecuronium bromide | Injection, powder for | 10 mg | Resolved | Available | Manufacturing | 20/10/2025 |
| salmeterol xinafoate~fluticasone propionate | Inhalation, powder for | 72.5 microgram/actuation~250 microgram/actuation | Resolved | Available | Unexpected increase in consumer demand | 20/10/2025 |
| desvenlafaxine | Tablet, modified release | 100 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 20/10/2025 |
| desvenlafaxine | Tablet, modified release | 50 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 20/10/2025 |
| methylphenidate hydrochloride | Capsule, modified release | 60 mg | Current | Limited Availability | Manufacturing | 20/10/2025 |
| ezetimibe~simvastatin | Tablet | 10 mg~40 mg | Resolved | Available | Unexpected increase in demand due to other sponsors unable to supply | 20/10/2025 |
| amiodarone hydrochloride | Tablet, uncoated | 100 mg | Current | Unavailable | Manufacturing | 20/10/2025 |
| sugammadex sodium | Injection, solution | 217.6 mg | Current | Unavailable | Manufacturing | 20/10/2025 |
| risperidone | Oral Liquid, solution | 1 mg/mL | Current | Limited Availability | Manufacturing | 20/10/2025 |
| rifampicin | Capsule, hard | 150 mg | Current | Limited Availability | Manufacturing | 20/10/2025 |
| Peginterferon alfa2a | Injection, solution | 135 microgram | Current | Unavailable | Unexpected increase in consumer demand | 20/10/2025 |
| Peginterferon alfa2a | Injection, solution | 180 microgram | Current | Unavailable | Unexpected increase in consumer demand | 20/10/2025 |
2025年10月27日